Clinical Utility of Caduet in Achieving Blood Pressure and Lipid Endpoints in a Specific Patient Population

Completed · Phase 4

Conditions studied: Hypertension, Dyslipidemia

In brief

The purpose is to demonstrate the utility of Caduet (amlodipine/atorvastatin) in the African American population

Key facts

Study ID

NCT00150384

Run by

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

People needed

500

Starts

2004-07-01

Expected to finish

2005-08-01

Last updated by the study team

2021-01-27

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• African American men and women with concurrent hypertension and dyslipidemia that is either treated or untreated
• Subjects must satisfy the blood pressure and LDL-C inclusion criteria for their respective Cardiovascular Risk group determined at screening

You may not qualify if…

• Subjects currently being treated with concomitant amlodipine and atorvastatin therapy, including Caduet
• Subjects with blood pressure at goal

Where it is running

• Pfizer Investigational Site — Birmingham, Alabama, United States
• Pfizer Investigational Site — Huntsville, Alabama, United States
• Pfizer Investigational Site — Little Rock, Arkansas, United States
• Pfizer Investigational Site — Los Angeles, California, United States
• Pfizer Investigational Site — Oakland, California, United States
• Pfizer Investigational Site — Pico Rivera, California, United States
• Pfizer Investigational Site — Bridgeport, Connecticut, United States
• Pfizer Investigational Site — Washington D.C., District of Columbia, United States
• Pfizer Investigational Site — Washington D.C., District of Columbia, United States
• Pfizer Investigational Site — Aventura, Florida, United States
• Pfizer Investigational Site — Gainesville, Florida, United States
• Pfizer Investigational Site — Jacksonville, Florida, United States
• Pfizer Investigational Site — Orlando, Florida, United States
• Pfizer Investigational Site — Pensacola, Florida, United States
• Pfizer Investigational Site — Vero Beach, Florida, United States
• Pfizer Investigational Site — Athens, Georgia, United States
• Pfizer Investigational Site — Atlanta, Georgia, United States
• Pfizer Investigational Site — Atlanta, Georgia, United States
• Pfizer Investigational Site — Atlanta, Georgia, United States
• Pfizer Investigational Site — Atlanta, Georgia, United States
• Pfizer Investigational Site — Augusta, Georgia, United States
• Pfizer Investigational Site — Columbus, Georgia, United States
• Pfizer Investigational Site — Columbus, Georgia, United States
• Pfizer Investigational Site — Decatur, Georgia, United States
• Pfizer Investigational Site — Birmingham, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.